期刊文献+

产超广谱β-内酰胺酶和质粒介导的AmpC酶肺炎克雷伯菌耐药性及基因型研究 被引量:47

Antibiotic Resistance and Genotyping of Plasmid- mediated Extended Spectrum Beta Lactamases and AmpC Beta Lactamases in Klebsiella pneumoniae
下载PDF
导出
摘要 目的 了解我院临床分离的肺炎克雷伯菌耐药性及超广谱β-内酰胺酶和质粒介导的AmpC酶基因型。 方法采用Microscan微生物鉴定仪、微量肉汤稀释法,测定临床分离的肺炎克雷伯菌对21种抗菌药物的敏感 性;采用聚合酶链反应(PCR)及测序技术分析超广谱β-内酰胺酶和质粒介导的AmpC酶基因型。结果 肺炎克 雷伯菌对亚胺培南全部敏感,对环丙沙星、哌拉西林/他唑巴坦、头孢他啶、头孢西丁、头孢哌酮/舒巴坦、阿莫西 林/舒巴坦、阿米卡星、头孢噻肟和头孢哌酮的耐药率分别为36.6%、38.3%、56.7%、63.4%、81.7%、86.7%、 96.6%、98.3%和98.3%,对其他药物的耐药率为100%;60株肺炎克雷伯菌全部扩增出TEM基因,有25株细 菌检出CTX-M-Ⅰ群基因,有54株细菌扩增出DHA基因,而PER和MIR(ACT-1)全部为阴性;且有21株肺炎 克雷伯菌同时携带CTX-M-Ⅰ群、DHA和TEM基因。结论我院临床分离的肺炎克雷伯菌为多重耐药菌,同时 存在CTX-M-3型超广谱β-内酰胺酶和DHA-1型质粒介导的AmpC酶,尚未发现PER型超广谱β-内酰胺酶和 MIR型质粒介导的AmpC酶。 OBJECTIVE To investigate the resistance and genotyping of plasmid-mediated extended spectrum beta lactamases (ESBLs) and AmpC beta lactamases (pAmpC) in Klebsiella pneumoniae (Kpn) isolated from Huanhu Hospital of Tianjin. METHODS A total of 60 Kpn strains were tested to 21 drugs in vitro susceptibility by Microscan MIC method. The PCR and DNA sequencing methods were used to determine the genotypes of ESBLs and pAmpC. RESULTS The 60 strains were multi-resistant, from them three beta-lactamase genes were found. There were TEM type broad-spectrum beta lactamases gene in 60 strains, CTX-M type ESBLs gene in 25 strains and DHA type pAmpC beta lactamases gene in 54 strains. CTX-M type ESBLs and DHA type pAmpC beta lactamases genes simultaneously occurred in 21 strains. CONCLUSIONS The resistance of Kpn isolated from Huanhu Hospital of Tianjin is a serious issue and at least three kinds of beta lactamases genes are existing.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2005年第3期256-260,共5页 Chinese Journal of Nosocomiology
基金 GLON-GEN细菌耐药基因研究专项目基金资助(20040301TJ)
关键词 肺炎克雷伯菌 超广谱Β-内酰胺酶 质粒 AMPC酶 Klebsiella pneumoniae Plasmid AmpC ESBLs
  • 相关文献

参考文献13

  • 1彭少华,李栋,施菁玲.慢性阻塞性肺病患者继发革兰阴性杆菌医院肺炎的菌型及耐药性研究[J].中华医院感染学杂志,2002,12(1):10-12. 被引量:42
  • 2陆坚,唐英春,吴本权,张扣兴,张天托,毕筱刚,朱家馨,谈淑卿.华南地区质粒介导超广谱β-内酰胺酶的基因分型研究[J].中华微生物学和免疫学杂志,2002,22(6):638-643. 被引量:98
  • 3Nordmann P. Trends in beta-lactamase resistance among Enterobacteriaceae[J]. Clin Infect Dis, 1998, Suppl 1: S100-S106.
  • 4Yan JJ, Ko WC, Jung YC, et al. Emergence of Klebsiella pneumoniae isolates producing inducible DHA-1 beta lactamase in a university hospital in Taiwan[J]. J Clin Microbiol, 2002,40(2): 3121-3126.
  • 5Philippon A, Arlet G, jacoby GA. Plasmid determined AmpC type beta lactamases [J]. Antimicrob Agents Chemother,2002, 46(5): 1-11.
  • 6Coudron PE, Moland ES, Thomson KS. Occurrence and detection of AmpC beta lactamase among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center[J]. j Clin Microbiol, 2000, 38(5): 1791-1796.
  • 7National Committee for Clinical Laboratory Standard. Perform ance standards for antimicrobial suspectibility testing[S]. Approved standard-eighth edition. NCCLS document M2-A8.Wayne, Pennsylvania: NCCLS, 2003.
  • 8Bradford PA. Extended-spectrum β-lactamases in the 21st Century: characterization, epidemiology, and detection of the important resistance threat [J]. Clin Microbiol Rev, 2001, 14(4): 933-951.
  • 9Decbamps C, Sirot D, Chanal C, et al. A 1998 survey of extended-spectrum beta lactamases in Enterobacteriaceae in France. The French Study Group[J]. Antimicrob Agents Chemother, 2000, 44(6): 3177-3179.
  • 10Knox JR. Extended spectrum and inhibitor resistant TEM-type β-lactamases: mutations, specificity and three-dimensional structure[J]. Antimicrob Agents Chemother, 1995, 39 (2):2593-2601.

二级参考文献15

  • 1Bingen EH, Desjardins P, Arlet G,et al. Molecular epidemiology of plasmid spread among extended broad-spectrum-β-lac-tamase-producing Klebsiella pneumoniae isolates in a pediatric hospital[J]. J Clin Microbiol, 1993, 31: 179.
  • 2National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests approved standard [S]. Seventh edition. NCCLS M100-S10(M7), January 2000.
  • 3Patterson JE, Hardin TC, Kelly CA, et al. Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsiella pneumoniae[J]. Infect Control Hosp Epidemiol, 2000, 21: 455-458.
  • 4Schiappa DA, Hayden MK, Matushek MG, et al. Cef-tazidime-resistant Klebsiella pneumoniae and Escherichia coli blood stream infection: a case-control and molecular epidemiologic investigation[J]. J Infect Dis, 1996, 174: 529-536.
  • 5萨姆布鲁克J 弗里奇EF 等.分子克隆实验指南(第二版)[M].北京:科学出版社,1999.1-1061.
  • 6National Committee for Clinical Labortory Standards for antimicrobial susceptibility testing[M].Ninth informational standards.Performance Standards M100-S9.Pennsylvania: NCCLS, 1999.1-103.
  • 7王振义, 孟承伟. 临床医学概要[M]. 北京: 人民卫生出版社, 1997. 241.
  • 8孙耕耘,毛宝龄.院内肺炎研究进展[J].中华医院感染学杂志,1995,5(4):63-66. 被引量:27
  • 9孙长贵,舒建,张丽君,曾贤铭,孙关忠.超广谱β-内酰胺酶大肠埃希菌对19种抗生素的耐药性[J].中华检验医学杂志,2000,23(1):44-44. 被引量:45
  • 10张勇昌,赵桂兰,赖伟忠.产超广谱β-内酰胺酶病原菌的检测及耐药性监测[J].中华医院感染学杂志,2001,11(6):469-470. 被引量:25

共引文献281

同被引文献292

引证文献47

二级引证文献326

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部